Canadian Association of Medical Oncologists (CAMO) Priority Announcement
SUMMARY
The Canadian Association of Medical Oncologists (CAMO) will provide funding for applications that are determined to be relevant to the following research priority areas described below:
- The field of medical oncology is rapidly changing, with the introduction of new drugs and biologics with an emphasis on targeted therapies, predictive and prognostic markers and translation of new therapies into practice. Medical oncologists wishing to pursue an academic career require further training in basic and clinical research; often completing a graduate degree in the process. To this end, the Canadian Association of Medical Oncologists (CAMO) will support individuals who are completing their Medical Oncology training in Canada to have additional clinical and/or fundamental (basic) research experience. It is expected that this targeted investment will build Canadian capacity and expertise in the area of oncology and will promote excellence in research through training awards.
The specific objectives of this funding opportunity are to: - Address scientific questions/problems related to basic science, clinical or translational research questions in medical oncology, such as new drug development, genetic basis of cancer, prognostic and predictive markers of outcome, and personalized approaches to systemic treatment of solid tumors;
- Address knowledge translation questions/problems related to integration of new therapies in clinical practice, population health related to cancer including treatment and quality indicators of cancer system performance, health outcomes research; and
- Develop the capacity in Canada to actively participate in these research areas by providing further training opportunities for medical oncologists completing training in Canada.
Funding will be provided for applications that are determined to be relevant to the following research priority areas: - Basic lab research
- Clinical trials
- Epidemiology
- Translational Research
- Educational research
- Population health
- Health Outcomes Research
SPECIFIC AWARDS
Two specific awards are offered this year IN ADDITION to the general CAMO fellowship using the same funding structure:
1. Boehringer Ingelheim Canada Ltd/CAMO Fellowship in Rare Cancers
- This fellowship project’s topic is to be focused on rare cancers – with preference for soft tissue sarcoma.
- Rare cancers should be defined in accordance with the Canadian Cancer Society which is any cancer with an incidence of lower than 6 per 100,000 people.
- Therefore, in Canada, rare cancers include but are not limited to:
Soft tissue sarcoma (including the heart), Kaposi sarcoma, renal pelvis and ureter cancer, penile cancer, eye cancer, bone cancer, salivary gland cancer, mesothelioma, gallbladder cancer, anal cancer, small intestine cancer, breast cancer in men, testicular cancer, laryngeal cancer, uterine cancer.
2. K. Jill Rigby Foundation/CAMO Fellowship
- This fellowship’s project is to be focused on research into less researched types of breast cancer and ultimately improve outcomes for others dealing with rarer types pf breast cancer where therapeutic options are limited.
- Research related to triple negative, lobular, ER-negative Her2-low, histiocytic and other rare histological forms of breast cancer.
- Focus may include, but does not need to be not limited to, research related to genomes and genetic mutations and dysregulation, tumor microenvironments, proteins, and tumor markers.
|
FUNDS AVAILABLE
- The total amount available for this funding opportunity is $80,000 (per fellowship). This amount may increase if additional funding partners decide to participate.
- The maximum amount awarded for a single award is $80,000 per annum for one (1) year. The award consists of an annual stipend of up to $75,000 and an annual research allowance of $5,000.
- Priority will be given to funding projects based on scientific merit, feasibility, originality, translatability to patient care and outcomes, and the best possible project irrespective of location of the fellowship within or outside of Canada.
SPECIFIC REQUIREMENTS
- Candidates must be Canadian citizens or landed immigrants.
- The candidate must hold a degree in Medicine, an FRCPC in Internal Medicine, be in their final year of training in a Royal College certified training program for Medical Oncology and be an associate member of CAMO. CAMO will give consideration to applications on a competitive basis from individuals in the first year of a fellowship-training program wishing to extend their training up to one-year.
- This funding opportunity is for research related to solid tumor malignancies only.
FELLOWSHIP DEADLINES
- The completed application package must be submitted to CAMO no later than November 3, 2024 at 5pm (Eastern Time).
- Primary applicants will receive a confirmation email of receipt of their application within 3 business days.
- The successful applicant(s) will be informed by email December 20, 2024with an announcement to the CAMO membership the following week.
APPLICATION PACKAGE AND CONTACT INFORMATION
The application package has been sent via email with this priority announcement, and can also be obtained on the CAMO website or by contacting Ms. Alexi Campbell at the email address below.
DOWNLOAD THE CAMO 2025 FELLOWSHIP APPLICATION PACKAGE Please send completed applications by email ONLY and indicate which fellowship you are applying for (please indicate all, not limited to one):
Ms. Alexi Campbell
Managing Director
Canadian Association of Medical Oncologists
Tel: 613.415.6033
Email: info@camo-acom.ca
| |
2025 APPLICATION DEADLINE
November 3, 2024 at 5:00 PM EST
|
